Enzymatica AB: Enzymatica signs agreement for ColdZyme with ABEX Pharmaceutica (Pty) Ltd for South Africa
Press releaseLund July 31, 2018 Enzymatica signs agreement for ColdZyme with ABEX Pharmaceutica (Pty) Ltd for South Africa Enzymatica has entered into a distribution agreement with ABEX for marketing and sales of ColdZyme® cold spray on the South African market. The product will be launched into the market in late 2018. ABEX will sell ColdZyme to all major pharmacy chains, independent pharmacies, as well as through non-conventional channels and grocery stores in South Africa. The company plans to launch ColdZyme in late 2018, but with a focus on the 2019 South African winter